Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
morpholine-4-carboxylic acid [1s-(2-benzyloxy-1r-cyano-ethylcarbamoyl)-3-methyl-butyl]amide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide is a synthetic small molecule belonging to the class of leucine derivatives and amides. It has a molecular formula of C21H30N4O4 and a molecular weight of approximately 402.5 g/mol. The compound is listed as an experimental drug, with no approved therapeutic indications or established mechanism of action reported in major chemical and pharmacological databases[1][2][3]. Its structure features a morpholine ring, benzyloxy group, cyano group, and methylated butyl side chain[3][4]. There is currently no information available regarding its clinical use, biological targets, or pharmacological activity.
- Other names
- (2S)-N-((1R)-2-(benzyloxy)-1-cyanoethyl)-4-methyl-2-((morpholine-4-carbonyl)amino)pentanamide(2S)-N-[(1R)-2-(benzyloxy)-1-cyanoethyl]-4-methyl-2-[(morpholine-4-carbonyl)amino]pentanamide
Beyond the preview
Go deeper on morpholine-4-carboxylic acid [1s-(2-benzyloxy-1r-cyano-ethylcarbamoyl)-3-methyl-butyl]amide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on morpholine-4-carboxylic acid [1s-(2-benzyloxy-1r-cyano-ethylcarbamoyl)-3-methyl-butyl]amide.